Chronic hepatitis C genotype 4 without cirrhosis

Also known as: Without cirrhosis Chronic hepatitis C genotype 4

Drug	Drug Name	Drug Description
DB09296	Ombitasvir	A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections.
DB09297	Paritaprevir	A direct acting antiviral agent used in combination with other antiviral agents for the treatment of Hepatitis C Virus (HCV) infections.

Drug	Drug Name	Target	Type
DB09296	Ombitasvir	Nonstructural protein 5A	target
DB09296	Ombitasvir	Cytochrome P450 2C8	enzyme
DB09296	Ombitasvir	P-glycoprotein 1	transporter
DB09296	Ombitasvir	ATP-binding cassette sub-family G member 2	transporter
DB09296	Ombitasvir	UDP-glucuronosyltransferase 1-1	enzyme
DB09297	Paritaprevir	NS3/4A protein	target
DB09297	Paritaprevir	Cytochrome P450 3A4	enzyme
DB09297	Paritaprevir	Cytochrome P450 3A5	enzyme
DB09297	Paritaprevir	ATP-binding cassette sub-family G member 2	transporter
DB09297	Paritaprevir	P-glycoprotein 1	transporter
DB09297	Paritaprevir	Solute carrier organic anion transporter family member 1B1	transporter
DB09297	Paritaprevir	Solute carrier organic anion transporter family member 1B3	transporter
DB09297	Paritaprevir	UDP-glucuronosyltransferase 1-1	enzyme

Drug	Drug Name	Phase	Status	Count